Login

Switch On Your HIV Smarts.

Author Archives: Liz Highleyman

No New HIV Infections Seen So Far in Kaiser San Francisco PrEP Program

No New HIV Infections Seen So Far in Kaiser San Francisco PrEP Program

, by Liz Highleyman

New data from 657 people enrolled in Kaiser Permanente’s PrEP program provides evidence of real-world PrEP success. Read More

Long-term HIV Remission Case Raises More Questions than Answers

Long-term HIV Remission Case Raises More Questions than Answers

, by Liz Highleyman

A French teenager with HIV has been off ART with undetectable viral load for 12 years after treatment, but she’s not “cured.” Read More

New Antiretrovirals, New Formulations, and New Strategies for HIV Treatment

New Antiretrovirals, New Formulations, and New Strategies for HIV Treatment

, by Liz Highleyman

For people with HIV, new treatment options offer flexibility and better safety profiles. Find out what’s coming down the drug pipeline. Read More

RAPID Program Leads to Faster HIV Suppression

RAPID Program Leads to Faster HIV Suppression

, by Liz Highleyman

A new study of San Francisco’s RAPID program verifies that starting treatment on the same day as an HIV diagnosis helps more people achieve viral suppression in fewer days. Read More

START Trial Shows Benefits of Early Treatment, Supports ART For All

START Trial Shows Benefits of Early Treatment, Supports ART For All

, by Liz Highleyman

Complete results from the START trial leave no room for doubt about benefits of early HIV treatment—and will influence development of world’s ART guidelines. Read More